The Microbiome: role in health and disease

Vertebrates become colonized with complex microbial communities in the
intestine and many other body surfaces soon after birth. Millions of years
of co-evolution have led this host-microbe interaction into a symbiotic
relationship in which the microbiota contributes to many host physiological
processes including building the intestinal epithelial barrier, development
of the immune system, protection against pathogen colonization, cell
renewal, and nutrient acquisition. Notably, several disorders have been
linked to the composition of the gut microbiota including inflammatory
bowel disease, obesity and diabetes. Although little is known about how the
microbial communities are formed and regulated in different individuals, it
is likely that strategies to alter their composition and plasticity will be part
of clinical medicine in the near future. The workshop will bring the
world’s leading scientists working in different aspects of the microbiome
to discuss recent advances in the field.
+ show speakers and program
Fredrik Bäckhed Sahlgrenska Center for Cardiovascular and
Metabolic Research/Wallenberg Laboratory;
Department of Molecular and Clinical Medicine,
University of Gothenburg. Gothenburg, Sweden.

adine Cerf-Bensussan INSERM U989, Fondation IMAGINE,
Université Paris Descartes. Paris, France.
Dusko S. Ehrlich Institut National de la Recherche Agronomique,
UMR1319 Micalis. Jouy-en-Josas, France.
Wendy S. Garrett Department of Immunology and Infectious
Diseases, Harvard School of Public Health;
Department of Medicine, Harvard Medical
School; Department of Medical Oncology, Dana-
Farber Cancer Institute / The Broad Institute of
MIT and Harvard. Boston / Cambridge, MA,
USA.
Francisco Guarner Digestive System Research Unit, University
Hospital Vall d'Hebron, Ciberehd. Barcelona
Spain.
Gunnar C. Hansson Department of Medical Biochemistry, University
of Gothenburg. Gothenburg, Sweden.
Wolf-Dietrich Hardt Institute of Microbiology, D-BIOL, ETH Zürich.
Zürich, Switzerland.
Stanley L. Hazen Center for Cardiovascular Diagnostics and
Prevention, Department of Cell Biology, Lerner
Research Institute, Cleveland Clinic. Cleveland,
OH, USA.
Lora V. Hooper The Howard Hughes Medical Institute;
Department of Immunology / The University of
Texas Southwestern Medical Center at Dallas.
Dallas, TX, USA.

aohiro Inohara Department of Pathology, University of Michigan
Medical School. Ann Arbor, MI, USA.
Dan R. Littman Molecular Pathogenesis Program, Howard Hughes
Medical Institute, The Kimmel Center for Biology
and Medicine of the Skirball Institute, New York
University School of Medicine. New York, NY,
USA.
Andrew J. Macpherson Mucosal Immunology Lab, Maurice Müller
Laboratories, University Clinic for Visceral
Surgery and Medicine, University of Bern. Bern,
Switzerland.
Sarkis K. Mazmanian Division of Biology, California Institute of
Technology. Pasadena, CA, USA.
Margaret J. McFall-
gai Department of Medical Microbiology and
Immunology, University of Wisconsin-Madison.
Madison, WI, USA.
Gabriel
úñez Department of Pathology and Comprehensive
Cancer Center, University of Michigan Medical
School. Ann Arbor, MI, USA.
Justin L. Sonnenburg Department of Microbiology and
Immunology, Stanford University School of
Medicine. Stanford, CA, USA.
George M. Weinstock The Genome Institute, Washington
University School of Medicine. St. Louis, MO,
USA.

8 Oct - 10 Oct 2012
Baeza
Spain
meeting website